Boston Therapeutics
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes (NCT03655535) | Boston Therapeutics | 2018-09-19 |
Track Boston Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.